FRET-biosensor assay can detect less than ng of the total protein from AD brain extract (Hitt et al., 2021), which is more sensitive than our seeded-tau aggregation assay that requires 25 ng total protein of AD brain extract. Here, MAPT is linked to Alzheimer disease.